A Clinical Overview of Monoamine Oxidase Inhibitors: Pharmacological Profile, Efficacy, Safety/Tolerability, and Strategies for Successful Outcomes in the Management of Major Depressive Disorders-Reference-Cited by-同舟云学术

A Clinical Overview of Monoamine Oxidase Inhibitors: Pharmacological Profile, Efficacy, Safety/Tolerability, and Strategies for Successful Outcomes in the Management of Major Depressive Disorders

Published:2014-11 Issue:11 Volume:44 Page:513-523
ISSN:0048-5713
Container-title:Psychiatric Annals
language:en
Short-container-title:Psychiatric Annals

Author:

Zajecka John M.,Zajecka Alexa M.

Publisher

SLACK, Inc.

Subject

Psychiatry and Mental health

Reference56 articles.

1. The catecholamine hypothesis of affective disorders: a review of supporting evidence 1965;Schildkraut JJ;J Neuropsychiatry Clin Neurosci,1995

2. STAR*D Investigators Group. Sequenced treatment alternatives to relieve depression (STAR*D): rationale and design;Rush AJ;Control Clin Trials,2004

3. Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression;Rush AJ;N Engl J Med,2006

4. A comparison of mirtazapine and nortriptyline following two consecutive failed medication treatments for depressed outpatients: A STAR*D report;Fava M;Am J Psychiatry,2006

5. STAR*D: the results begin to roll in;Menza M;Am J Psychiatry,2006

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety of Ketamine Augmentation to Monoamine Oxidase Inhibitors in Treatment-Resistant Depression: A Systematic Literature Review and Case Series;J CLIN PSYCHIAT;2022

2. A reassessment of the safety profile of monoamine oxidase inhibitors: elucidating tired old tyramine myths;Journal of Neural Transmission;2018-09-25

3. Curcumin-based pyrazoline analogues as selective inhibitors of human monoamine oxidase A;MedChemComm;2018

4. Triple Reuptake Inhibitors as Potential Therapeutics for Depression and Other Disorders: Design Paradigm and Developmental Challenges;Journal of Medicinal Chemistry;2017-07-21

5. Monoamine Oxidase Inhibitors;Critical Care Toxicology;2017